KRAS and brain ischemia: Indeed, ERK activation is causally linked to inflammation in many instances: oncogenic KRAS G12V drives inflammation in mice and human leukemic monocytes (66), and ERK inhibition blocks inflammation due to cerebral ischemia in mice (74).